• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用加权基因共表达网络分析(WGCNA)和机器学习鉴定甲状腺癌生物标志物

Identification of thyroid cancer biomarkers using WGCNA and machine learning.

作者信息

Hu Gaofeng, Niu Wenyuan, Ge Jiaming, Xuan Jie, Liu Yanyang, Li Mengjia, Shen Huize, Ma Shang, Li Yuanqiang, Li Qinglin

机构信息

Wenzhou Medical University, Wenzhou, Zhejiang, China.

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.

出版信息

Eur J Med Res. 2025 Apr 5;30(1):244. doi: 10.1186/s40001-025-02466-x.

DOI:10.1186/s40001-025-02466-x
PMID:40186253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11971869/
Abstract

OBJECTIVE

The incidence of thyroid cancer (TC) is increasing in China, largely due to overdiagnosis from widespread screening and improved ultrasound technology. Identifying precise TC biomarkers is crucial for accurate diagnosis and effective treatment.

METHODS

TC patient data were obtained from TCGA. DEGs were analyzed using DESeq2, and WGCNA identified gene modules associated with TC. Machine learning algorithms (XGBoost, LASSO, RF) identified key biomarkers, with ROC and AUC > 0.95 indicating strong diagnostic performance. Immune cell infiltration and biomarker correlation were analyzed using CIBERSORT.

RESULTS

Four key genes (P4HA2, TFF3, RPS6KA5, EYA1) were found as potential biomarkers. High P4HA2 expression was associated with suppressed anti-tumor immune responses and promoted disease progression. In vitro studies showed that P4HA2 upregulation increased TC cell growth and migration, while its suppression reduced these activities.

CONCLUSION

Through bioinformatics and experimental validation, we identified P4HA2 as a key potential thyroid cancer biomarker. This finding provides new molecular targets for diagnosis and treatment. P4HA2 has the potential to be a diagnostic or therapeutic target, which could have significant implications for improving clinical outcomes in thyroid cancer patients.

摘要

目的

在中国,甲状腺癌(TC)的发病率正在上升,这在很大程度上归因于广泛筛查和超声技术改进导致的过度诊断。确定精确的TC生物标志物对于准确诊断和有效治疗至关重要。

方法

从TCGA获取TC患者数据。使用DESeq2分析差异表达基因(DEG),并通过加权基因共表达网络分析(WGCNA)确定与TC相关的基因模块。机器学习算法(XGBoost、套索回归、随机森林)确定关键生物标志物,受试者工作特征曲线(ROC)和曲线下面积(AUC)>0.95表明具有强大的诊断性能。使用CIBERSORT分析免疫细胞浸润和生物标志物相关性。

结果

发现四个关键基因(P4HA2、TFF3、RPS6KA5、EYA1)作为潜在生物标志物。P4HA2高表达与抗肿瘤免疫反应受抑制和疾病进展促进相关。体外研究表明,P4HA2上调增加TC细胞生长和迁移,而抑制P4HA2则降低这些活性。

结论

通过生物信息学和实验验证,我们确定P4HA2为关键的潜在甲状腺癌生物标志物。这一发现为诊断和治疗提供了新的分子靶点。P4HA2有潜力成为诊断或治疗靶点,这可能对改善甲状腺癌患者的临床结局具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/7f04740ae1b5/40001_2025_2466_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/b32a77ea6474/40001_2025_2466_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/3eef75bcbdd1/40001_2025_2466_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/c971a95227ac/40001_2025_2466_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/93dab74b7ea4/40001_2025_2466_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/f97b49ebadac/40001_2025_2466_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/ccf263521819/40001_2025_2466_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/22df4b86bd45/40001_2025_2466_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/8157d8cc40fd/40001_2025_2466_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/7f04740ae1b5/40001_2025_2466_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/b32a77ea6474/40001_2025_2466_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/3eef75bcbdd1/40001_2025_2466_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/c971a95227ac/40001_2025_2466_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/93dab74b7ea4/40001_2025_2466_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/f97b49ebadac/40001_2025_2466_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/ccf263521819/40001_2025_2466_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/22df4b86bd45/40001_2025_2466_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/8157d8cc40fd/40001_2025_2466_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f457/11971869/7f04740ae1b5/40001_2025_2466_Fig9_HTML.jpg

相似文献

1
Identification of thyroid cancer biomarkers using WGCNA and machine learning.使用加权基因共表达网络分析(WGCNA)和机器学习鉴定甲状腺癌生物标志物
Eur J Med Res. 2025 Apr 5;30(1):244. doi: 10.1186/s40001-025-02466-x.
2
Revolutionary multi-omics analysis revealing prognostic signature of thyroid cancer and subsequent in vitro validation of SNAI1 in mediating thyroid cancer progression through EMT.革命性的多组学分析揭示甲状腺癌的预后特征,并随后对SNAI1通过上皮-间质转化介导甲状腺癌进展进行体外验证。
Clin Exp Med. 2024 Jun 13;24(1):127. doi: 10.1007/s10238-024-01387-z.
3
Integrative bioinformatics and machine learning identify key crosstalk genes and immune interactions in head and neck cancer and Hodgkin lymphoma.整合生物信息学和机器学习识别头颈癌和霍奇金淋巴瘤中的关键串扰基因和免疫相互作用。
Sci Rep. 2025 May 6;15(1):15745. doi: 10.1038/s41598-025-99017-5.
4
Identification and validation of potential common biomarkers for papillary thyroid carcinoma and Hashimoto's thyroiditis through bioinformatics analysis and machine learning.通过生物信息学分析和机器学习鉴定和验证甲状腺乳头状癌和桥本甲状腺炎的潜在共同生物标志物。
Sci Rep. 2024 Jul 6;14(1):15578. doi: 10.1038/s41598-024-66162-2.
5
The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis.基于生物信息学分析的甲状腺癌中CCL17的表达及其对肿瘤免疫的潜在预后价值
Sci Rep. 2024 Dec 30;14(1):31580. doi: 10.1038/s41598-024-75750-1.
6
Identification and Validation of Four Serum Biomarkers With Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms.基于机器学习算法的四种具有最佳胃癌诊断和预后潜力的血清生物标志物的鉴定与验证
Cancer Med. 2025 Mar;14(6):e70659. doi: 10.1002/cam4.70659.
7
Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.综合生物信息学结合机器学习分析银屑病和宫颈鳞状细胞癌中的共享生物标志物和通路。
Front Immunol. 2024 May 28;15:1351908. doi: 10.3389/fimmu.2024.1351908. eCollection 2024.
8
Identification of potential biomarkers of papillary thyroid carcinoma.甲状腺乳头状癌潜在生物标志物的鉴定。
Endocrine. 2025 Feb;87(2):758-771. doi: 10.1007/s12020-024-04068-9. Epub 2024 Oct 14.
9
The role and machine learning analysis of mitochondrial autophagy-related gene expression in lung adenocarcinoma.线粒体自噬相关基因表达在肺腺癌中的作用及机器学习分析
Front Immunol. 2025 Apr 17;16:1509315. doi: 10.3389/fimmu.2025.1509315. eCollection 2025.
10
Identification and functional characterization of hub genes CLTA, EDIL3, HAPLN1, and HIP1 as diagnostic biomarkers and therapeutic targets in thyroid cancer and Hashimoto's thyroiditis.枢纽基因CLTA、EDIL3、HAPLN1和HIP1作为甲状腺癌和桥本甲状腺炎诊断生物标志物及治疗靶点的鉴定与功能表征
Clin Exp Med. 2025 May 15;25(1):162. doi: 10.1007/s10238-025-01689-w.

引用本文的文献

1
Screening of hub genes and immunocytes related to tendon injury based on bioinformatics and machine learning models.基于生物信息学和机器学习模型筛选与肌腱损伤相关的枢纽基因和免疫细胞
Sci Rep. 2025 Aug 26;15(1):31432. doi: 10.1038/s41598-025-15210-6.

本文引用的文献

1
Deciphering the value of anoikis-related genes in prognosis, immune microenvironment, and drug sensitivity of laryngeal squamous cell carcinoma.解读失巢凋亡相关基因在喉鳞状细胞癌预后、免疫微环境及药物敏感性中的价值。
Pathol Res Pract. 2025 Apr;268:155849. doi: 10.1016/j.prp.2025.155849. Epub 2025 Feb 25.
2
The Correlation Between Biological Markers and Prognosis in Thyroid Cancer.甲状腺癌生物学标志物与预后的相关性
Biomedicines. 2024 Dec 12;12(12):2826. doi: 10.3390/biomedicines12122826.
3
Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers.
社论:内分泌相关癌症的靶向治疗与生物标志物研究进展
Front Endocrinol (Lausanne). 2024 Dec 11;15:1533623. doi: 10.3389/fendo.2024.1533623. eCollection 2024.
4
Detection of the Mutation in Circulating Free Nucleic Acids as a Biomarker of Thyroid Cancer: A Review.循环游离核酸中的突变检测作为甲状腺癌生物标志物的研究综述
J Clin Med. 2024 Sep 12;13(18):5396. doi: 10.3390/jcm13185396.
5
Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN).使用全球癌症统计数据(GLOBOCAN)对2020年至2022年期间的癌症概况进行比较研究。
J Natl Cancer Cent. 2024 May 7;4(2):128-134. doi: 10.1016/j.jncc.2024.05.001. eCollection 2024 Jun.
6
Cancer incidence and mortality in China, 2022.2022年中国癌症发病率与死亡率
J Natl Cancer Cent. 2024 Feb 2;4(1):47-53. doi: 10.1016/j.jncc.2024.01.006. eCollection 2024 Mar.
7
P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma.P4HA2 通过调节口腔鳞状细胞癌中的 PI3K/AKT 信号通路促进增殖、侵袭和转移。
Sci Rep. 2024 Jul 1;14(1):15023. doi: 10.1038/s41598-024-64264-5.
8
P4HA2 hydroxylates SUFU to regulate the paracrine Hedgehog signaling and promote B-cell lymphoma progression.P4HA2 羟化 SUFU 以调节旁分泌 Hedgehog 信号通路并促进 B 细胞淋巴瘤的进展。
Leukemia. 2024 Aug;38(8):1751-1763. doi: 10.1038/s41375-024-02313-8. Epub 2024 Jun 22.
9
P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.P4HA2 通过 PI3K/AKT 信号通路促进头颈部鳞状细胞癌的进展和 EMT。
Med Oncol. 2024 May 23;41(6):163. doi: 10.1007/s12032-024-02358-w.
10
Prognostic value of CDKN2A in head and neck squamous cell carcinoma via pathomics and machine learning.基于病理组学和机器学习的 CDKN2A 在头颈部鳞状细胞癌中的预后价值。
J Cell Mol Med. 2024 May;28(9):e18394. doi: 10.1111/jcmm.18394.